Against this backdrop, a team led by Professor Zhang Han and Associate Professor Chen Zhi from Shenzhen University in China , has demonstrated an innovative approach that combines DNA origami, CRISPR ...

Liquid biopsy is increasingly recognized as a promising tool for cancer detection and treatment monitoring, yet its effectiveness is often limited by the extremely low levels of tumor-derived DNA ...

The model suggests that negative KRAS findings are believable when the maximum of APC and TP53 frequencies is at least 8% (corresponding posterior probability of false negative <5%). Validation ...

Researchers have developed a novel way of detecting brain cancer, using nanowires to ‘catch-and-release’ DNA in urine, enabling them to detect mutations that signify the presence of a brain tumor.

As new variants of the SARS-CoV-2 virus continue to emerge, concerns have been raised about the performance of rapid antigen tests. The team, which was funded by NIH's Rapid Acceleration of ...

Bryan Tieman is a Principal Scientist in the Diagnostics Division of Abbott Laboratories (IL, USA) and is a member of the Biologics Discovery Group where he creates binding agents and targets for the ...

Using the LightCycler 480 System for Discovery and Analysis of Genetic Variation LightCycler® Real-time PCR Systems from Roche (www.roche.com) are efficient platforms for genetic variation research.

One reason that researchers do not always find specific DNA sequence variations in genes associated with muscular dystrophy (MD) is that they lack a reliable and cost-effective assay to detect point ...